Revolution Medicines · 2 days ago
National Director, Field Reimbursement
United States
Full-time
Remote
Director/Executive
$238K/yr - $265K/yr
8+ years expRevolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The Director, Field Reimbursement will lead the strategy, development, and execution of the Field Reimbursement Team to support the launch and lifecycle management of the company's approved therapies.
Health CareLife ScienceMedical
Responsibilities
Build and lead a high-performing national team of FRDs
Define team accountabilities, hiring profiles, performance metrics, and engagement models
Establish clear KPIs for patient access, issue resolution time, documentation quality, and account satisfaction—ensuring all FRDs meet or exceed expectations
Drive a culture of urgency, ownership, and patient-centricity through coaching, field rides, dashboard reviews, and performance management
Ensure FRDs proactively identify, triage, and escalate complex access challenges—including PA delays, denials, appeals hurdles, specialty pharmacy routing issues, and affordability barriers, and more
Build and oversee standardized escalation frameworks with the HUB, specialty pharmacies, payer teams, and field partners to ensure rapid and compliant issue resolution
Maintain visibility into high-priority or at-risk cases, ensuring swift cross-functional engagement and timely resolution
Implement and manage data dashboards tracking patient access milestones (benefit verification, PA status, appeals, specialty and noncommercial pharmacy dispense timing)
Lead and set expectations for transitioning all EAP patients with urgency upon FDA approval
Monitor all patient cases for delays or bottlenecks, ensuring immediate FRD follow-up for unresolved cases
Enforce rigorous documentation standards to ensure access barriers are tracked, addressed, and compliantly resolved in alignment with a 'no patient left behind' mindset
Provide coaching, training, and ongoing development to FRDs
Foster a culture grounded in compliance, customer centricity, urgency, and collaboration
Develop the national FRD launch strategy aligned with HUB, distribution strategies, Market Access, and Corporate strategies
Partner cross-functionally with Market Access, Patient Services, Trade/Distribution, Marketing, Sales, and other teams as needed to ensure seamless patient initiation and continuity of therapy as prescribed
Design and refine FRD role scope, field standards, KPIs, reporting structures, and rules of engagement
Identify and communicate regional access challenges and insights to shape brand strategy, messaging, and resource planning
Oversee provider and account engagement to resolve access barriers (coverage, coding, billing, SP coordination, and appeals education)
Ensure FRDs provide non-promotional, compliant education on coverage, reimbursement, and financial assistance pathways
Establish clear field escalation workflows with HUB, specialty pharmacy partners, field sales, and other internal stakeholders
Monitor field performance across regions and adjust tactics based on real-time insights and evolving market dynamics
Partner closely with the Patient Services team to ensure service design, SLAs, and escalation paths support the oral oncology launch
Collaborate with PAP, copay, and distribution partners to ensure FRDs understand and appropriately communicate program offerings
Work with Trade/Distribution to uncover SP insights and national account dynamics impacting access
Serve as the key Field Access & Reimbursement voice across brand leadership, Market Access, and cross-functional launch teams
Ensure all FRD activities align with legal, regulatory, and compliance standards for oncology field reimbursement roles
Maintain and enforce 'Rules of the Road,' including field engagement parameters, documentation standards, and coordination with Sales and Medical Affairs
Lead training on compliant communication related to access, reimbursement, affordability, and patient support services
Analyze field insights to identify systemic barriers, payer trends, and opportunities to accelerate patient access
Partner with analytics and Patient Services teams to develop dashboards and performance reporting
Track and report KPIs, including access resolution times, appeal outcomes, account satisfaction, and FRD productivity
Present field insight summaries and strategic recommendations to senior leadership
Qualification
Required
Bachelor's degree required
8–12+ years of experience in oncology market access, field reimbursement, or patient services, with 3+ years leading field teams
Proven experience supporting specialty or oral oncology launches (start-up or high-growth environments strongly preferred)
Deep understanding of payer dynamics, specialty pharmacy and distribution models, reimbursement processes, and patient support program operations
Exceptional leadership, analytical, communication, and cross-functional influencing skills
Demonstrated ability to lead national teams and collaborate effectively across functions
Willingness to travel 40–60% for field rides, launches, account engagements, and cross-functional meetings
Strategic Leadership & Execution
Patient-Centric Mindset
Cross-Functional Collaboration
Operational Excellence
Analytical and Data-Driven Decision Making
Compliance & Ethical Integrity
Preferred
Advanced degree (MBA, MPH, or health-related field)
Benefits
Competitive cash compensation
Robust equity awards
Strong benefits
Significant learning and development opportunities
Company
Revolution Medicines
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
501-1000 employees
H1B Sponsorship
Revolution Medicines has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (13)
2024 (18)
2023 (15)
2022 (8)
2021 (1)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$2.25BKey Investors
Royalty PharmaBoxer CapitalNextech Invest
2025-06-24Post Ipo Debt· $250M
2024-12-02Post Ipo Equity· $750M
2023-03-02Post Ipo Equity· $323.6M
Leadership Team
Luan Wilfong
Chief Human Resources Officer
Steve Kelsey
President
Recent News
2026-01-11
The Motley Fool
2026-01-11
Company data provided by crunchbase